Display search results for ** instead (812 products)
29 Jul 2020  |  Global
IoT Technologies with Advanced Artificial Intelligence to Redefine Coronavirus Care Management and Prevent Future Pandemic
Before the introduction of Internet of Things (IoT) technologies in healthcare, patients’ interactions with doctors were often limited to clinic visits, text or tele communications. Due to this doctors were not able to monitor patients’ health continuously and this was affecting the overall treatment outcome. To address this clinical concern, r...
24 Jul 2020  |  Global
INNOVATIONS AND GROWTH OPPORTUNITIES IN BLOOD GAS ANALYZER, POINT OF CARE TESTING, WOUND CARE, DIABETES MANAGEMENT, AND SLEEP MONITORING SOLUTIONS
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices and diagnostic industry. The innovations span the breadth of market segments in the MedTech space such as hematology and immunoassay analyzers, point of care testing solutions for critical care patients, f...
17 Jul 2020  |  Global
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses recent advances in gene therapy, automated bioanalytics, drug discovery technologies, biomarker platforms, and targeted delivery. The research also provides technological insights across inflammation, infectious diseases, and microbiomics. The Life...
28 Jul 2020  |  North America
Taiwan, Estonia, and Finland Emerging as Key Markets Fueling Growth Opportunities in Precision Medicine Informatics
Precision medicine is transitioning toward wider acceptance, due to mounting payer pressures and regulatory changes that are shifting pharma businesses from prescriptive to more predictive and personalized models. Emergence of value-based reimbursement models and healthcare consumerism trends are helping move the treatment model from ‘one-size-fi...
24 Jul 2020  |  North America
Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies
With this research service, Frost & Sullivan’s Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapi...
09 Jul 2020  |  North America
Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’
Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...
07 Jul 2020  |  Global
Emerging Chimeric Antigen Receptor (CAR) T-cell Therapy Platforms
This research identifies some the key developments across CAR-T cell therapies and provides insights across technological, IP, and investment landscapes. The study also provides an analysis of the competitive landscape while highlighting the key growth opportunities within the CAR-T cell therapy platform.
29 Jun 2020  |  Global
Leveraging Growth Opportunities in Emerging Economies Spurred by Affordable and Accessible Medical Device Innovations
According to the World Health Organization, at least half of the world’s population do not have access to essential health services due to the high healthcare costs. Frugal medical device innovations can improve the healthcare accessibility and quality of care to the people, especially those at lower socio-economic status. This research service (...
29 Jun 2020  |  Global
Growing Viral Vector Contract Development Manufacturing Landscape
The rise in gene therapies over the last few years has created a huge opportunity for viral vector Contract Research Development Organization (CMO/CDMO) to fill the gap of high demand and shortage of viral vectors. As of January 2020, the US Food and Drug Administration FDA has approved four gene therapies and claims to have over 900 therapies i...
26 Jun 2020  |  Global
Innovations in COVID-19 Diagnostics, Digital Therapeutics, Robotic Systems, Wearables, and Ocular Screening
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The innovations span the breadth of market segments in the MedTech space: novel COVID-19 assays, digital microscopes, FDA approved digital medicine, wearable patient monitoring solution...